Is BLUE Stock A Buy or Sell?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact,...
Posts Tagged ‘NASDAQ:BLUE’
Where Do Hedge Funds Stand On bluebird bio Inc (BLUE)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Were These Hedge Funds Wrong About Buying bluebird bio Inc (BLUE)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed...
Should I Buy bluebird bio Inc (BLUE)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish...
Were Hedge Funds Right About bluebird bio Inc (BLUE)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Here is What Hedge Funds Think About bluebird bio Inc (BLUE)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first...
Is bluebird bio Inc (BLUE) A Good Stock To Buy?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Hedge Fund and Insider Trading News: Paul Singer, Jeffrey Talpins, PointState Capital, Brevan Howard Asset Management, Sutter Rock Capital Corp (SSSS), Nordson Corporation (NDSN), and More
Hedge Fund PointState Stops Clients From Cashing Out in Full (Bloomberg) PointState Capital, the macro hedge fund started by former traders for billionaire...
Is bluebird bio Inc (BLUE) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Is bluebird bio Inc (BLUE) Going To Burn These Hedge Funds ?
Is bluebird bio Inc (NASDAQ:BLUE) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research...
Is bluebird bio Inc (BLUE) A Good Stock To Buy?
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions...
Did Hedge Funds Drop The Ball On bluebird bio Inc (BLUE) ?
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why...
Is bluebird bio Inc (BLUE) A Good Stock To Buy?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter. NASDAQ and Russell...
Hedge Fund and Insider Trading News: Brevan Howard Asset Management, EJF Capital, David Einhorn, CoreSite Realty Corp (COR), Caesars Entertainment Co. (CZR), Restoration Robotics Inc (HAIR), and More
Brevan Howard Cuts Office Perks in London Headquarters (Bloomberg) Brevan Howard Asset Management, the hedge fund manager run by billionaire Alan Howard...
Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value...
bluebird bio Inc (BLUE), Iqvia Holdings Inc (IQV): Four Biotech Stocks to Buy Now
Healthcare sector has proven itself to be one of the most resilient sectors of the US economy. Since healthcare cannot be outsourced and represents an...
Here’s What’s So Important About The bluebird bio Inc (BLUE) Data
bluebird bio Inc (NASDAQ:BLUE) is up sharply pre market on Thursday, as the company put out fresh interim data from a phase I study of its multiple myeloma...
Is bluebird bio Inc (BLUE) A Good Stock To Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...
Cupps Capital Slashes Portfolio in Q3, But Couldn’t Stop Buying These 5 Stocks
Drew Cupps‘ Chicago-based asset management firm, Cupps Capital Management, has been in the news of late after it announced that its five-member...
Spark Therapeutics Inc (ONCE) and Other Profitable Healthcare Picks of Casdin Capital
At Insider Monkey, we track some 750 hedge funds and other institutional investors. We analyze their 13F filings and determine stocks that they are collectively...
This Biotech Hedge Fund’s Stock Picks Killed It in Q3
Hedge funds returned about 4% so far this year and underperformed the S&P 500 Index again. Hedge fund investors have been withdrawing their capital...
What is Going On With These 4 Plunging Stocks?
Shares of Freeport-McMoRan Inc (NYSE:FCX), Qiagen NV (NASDAQ:QGEN), McKesson Corporation (NYSE:MCK), and bluebird bio Inc (NASDAQ:BLUE) are deep in the...
Why Are Investors Heading For The Exits In These Five Stocks Today?
In yet another volatile trading session, the S&P 500 is off by more than 0.8% and the NASDAQ is down by 0.84% as investors weigh the negative implications...
Hedge Funds Aren’t Crazy About bluebird bio Inc (BLUE) Anymore
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors...
bluebird bio Inc (BLUE), Nektar Therapeutics (NKTR) Among Billionaire Stan Druckenmiller’s Top Small-Cap Picks
Stan Druckenmiller’s Duquesne Family Office LLC, previously Duquesne Capital, has filed its 13F for the reporting period of March 31. Druckenmiller...
Biogen Idec Inc (BIIB), Celgene Corporation (CELG), bluebird bio Inc (BLUE): Stanley Druckenmiller Bets on Biotech and Wins
In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40...
Druckenmiller, Buffett At Odds On International Business Machines Corp. (IBM): What Do Hedge Funds Think? Plus Druckenmiller’s Top New Picks
Duquesne Capital’s Stanley Druckenmiller respects Warren Buffett’s opinion on International Business Machines Corp. (NYSE:IBM); he just doesn’t...
Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks
Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange...
